Halozyme Therapeutics Ownership 2024 | Who Owns Halozyme Therapeutics Now?
Institutional Ownership
24.47%
Insider Ownership
1.08%
Retail Ownership
74.44%
Institutional Holders
218.00
Halozyme Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 13.88% | 0.02% | 17,619,937 | -621,611 | -3.41% | 922,579,902 | Jun 30, 2024 |
| VANGUARD GROUP INC | 10.15% | 0.01% | 12,881,459 | -167,794 | -1.29% | 674,473,194 | Jun 30, 2024 |
| STATE STREET CORP | 4.58% | 0.01% | 5,814,207 | -673,096 | -10.38% | 304,431,879,000 | Jun 30, 2024 |
| SNYDER CAPITAL MANAGEMENT L P | 3.18% | 4.74% | 4,039,912 | -77,315 | -1.88% | 211,529,792 | Jun 30, 2024 |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 2.93% | 0.29% | 3,717,264 | -73,966 | -1.95% | 194,635,943 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 2.80% | 0.06% | 3,549,075 | -117,249 | -3.20% | 185,829,567 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 2.42% | 0.18% | 3,077,527 | 86,402 | 2.89% | 161,139,000 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 2.42% | 0.01% | 3,071,854 | -168,643 | -5.20% | 160,842,277 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.39% | 0.01% | 3,029,230 | 1,846 | 0.06% | 158,640,545 | Jun 30, 2024 |
| TD ASSET MANAGEMENT INC | 1.86% | 0.12% | 2,365,983 | -175,283 | -6.90% | 123,882,870 | Jun 30, 2024 |
| INVESCO LTD. | 1.75% | 0.02% | 2,223,938 | 135,528 | 6.49% | 116,445,394 | Jun 30, 2024 |
| GW&K INVESTMENT MANAGEMENT, LLC | 1.72% | 1.04% | 2,180,005 | -16,872 | -0.77% | 114,145,000 | Jun 30, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 1.65% | 1.31% | 2,090,701 | 231,860 | 12.47% | 109,469,104 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.50% | 0.03% | 1,897,759 | 209,530 | 12.41% | 99,363,016 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 1.44% | 0.01% | 1,825,656 | 128,504 | 7.57% | 95,591,349 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 1.41% | 0.02% | 1,796,035 | 4,131 | 0.23% | 94,040,393,000 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.41% | 0.02% | 1,787,548 | 120,069 | 7.20% | 93,596,013 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 1.26% | 0.02% | 1,601,598 | -50,012 | -3.03% | 83,859,672 | Jun 30, 2024 |
| EPOCH INVESTMENT PARTNERS, INC. | 1.13% | 0.34% | 1,436,042 | 2,430 | 0.17% | 75,191,159 | Jun 30, 2024 |
| STEPHENS INVESTMENT MANAGEMENT GROUP LLC | 1.12% | 1.04% | 1,421,904 | -124,762 | -8.07% | 74,450,893 | Jun 30, 2024 |
Halozyme Therapeutics's largest institutional shareholder is BLACKROCK INC., holding 13.88% of the company's total share outstanding, currently valued at $922.58M. The top 10 institutional shareholders own together 46.61% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 3.18% | 4.74% | 4,039,912 | -77,315 | -1.88% | 211,529,792 | Jun 30, 2024 |
| FUTURE FUND LLC | 0.03% | 4.74% | 36,295 | 24,020 | 195.68% | 1,888,066 | Jun 30, 2024 |
| BERNZOTT CAPITAL ADVISORS | 0.15% | 4.52% | 187,249 | -22,555 | -10.75% | 9,804,358 | Jun 30, 2024 |
| STEAMBOAT CAPITAL PARTNERS, LLC | 0.14% | 3.41% | 177,555 | 5,606 | 3.26% | 9,296,780 | Jun 30, 2024 |
| 2XIDEAS AG | 0.39% | 3.26% | 498,957 | -16,505 | -3.20% | 26,125,389 | Jun 30, 2024 |
| KOA WEALTH MANAGEMENT, LLC | 0.06% | 3.26% | 73,568 | -848 | -1.14% | 3,852,020 | Jun 30, 2024 |
| CASTELLAN GROUP | 0.09% | 2.71% | 108,922 | 108,922 | 100.00% | 5,703,156 | Jun 30, 2024 |
| HARVEY CAPITAL MANAGEMENT INC | 0.15% | 2.56% | 186,040 | 4,550 | 2.51% | 9,741,054 | Jun 30, 2024 |
| DOHENY ASSET MANAGEMENT /CA | 0.10% | 1.89% | 123,560 | 123,560 | 100.00% | 3,313,000 | Jun 30, 2024 |
| CHASE INVESTMENT COUNSEL CORP | 0.07% | 1.80% | 93,777 | 93,777 | 100.00% | 5,182,000 | Jun 30, 2024 |
| PIER CAPITAL, LLC | 0.17% | 1.72% | 220,447 | -2,185 | -0.98% | 11,542,605 | Jun 30, 2024 |
| GRANITE INVESTMENT PARTNERS, LLC | 0.59% | 1.63% | 752,839 | -58,619 | -7.22% | 39,418,650 | Jun 30, 2024 |
| SHAKER INVESTMENTS LLC/OH | 0.05% | 1.52% | 66,928 | 14,245 | 27.04% | 3,504,350 | Jun 30, 2024 |
| PENN CAPITAL MANAGEMENT COMPANY, LLC | 0.24% | 1.50% | 300,670 | 28,074 | 10.30% | 15,800,874 | Jun 30, 2024 |
| MOODY ALDRICH PARTNERS LLC | 0.11% | 1.38% | 135,512 | 11,588 | 9.35% | 7,095,408 | Jun 30, 2024 |
| MESIROW INSTITUTIONAL INVESTMENT MANAGEMENT, INC. | 0.23% | 1.33% | 289,805 | -74,242 | -20.39% | 15,174,190 | Jun 30, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 1.65% | 1.31% | 2,090,701 | 231,860 | 12.47% | 109,469,104 | Jun 30, 2024 |
| EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. | 0.11% | 1.27% | 140,269 | 180 | 0.13% | 7,345,888 | Jun 30, 2024 |
| HODGES CAPITAL MANAGEMENT INC. | 0.27% | 1.19% | 338,856 | 21,811 | 6.88% | 17,742,500 | Jun 30, 2024 |
| REDWOOD INVESTMENTS, LLC | 0.05% | 1.06% | 59,904 | -17,402 | -22.51% | 3,117,200 | Jun 30, 2024 |
The largest Halozyme Therapeutics shareholder by % of total assets is SNYDER CAPITAL MANAGEMENT L P. The company owns 4.04M shares of Halozyme Therapeutics (HALO), representing 4.74% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NORGES BANK | 0.96% | 0.01% | 1,216,161 | 1,216,161 | 100.00% | 63,678,190 | Jun 30, 2024 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 0.67% | 0.44% | 846,227 | 602,194 | 246.77% | 44,308,447 | Jun 30, 2024 |
| BOSTON TRUST WALDEN CORP | 0.35% | 0.17% | 443,295 | 443,295 | 100.00% | 23,210,926 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.33% | 0.01% | 423,190 | 291,122 | 220.43% | 22,158,228 | Jun 30, 2024 |
| HANDELSBANKEN FONDER AB | 0.88% | 0.25% | 1,112,969 | 284,300 | 34.31% | 58,275,000 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.34% | 0.01% | 432,024 | 271,070 | 168.41% | 22,620,778 | Jun 30, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 1.65% | 1.31% | 2,090,701 | 231,860 | 12.47% | 109,469,104 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.18% | 0.07% | 227,122 | 227,122 | 100.00% | 11,892,108 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.50% | 0.03% | 1,897,759 | 209,530 | 12.41% | 99,363,016 | Jun 30, 2024 |
| LOMBARD ODIER ASSET MANAGEMENT (EUROPE) LTD | 0.16% | 0.50% | 200,000 | 200,000 | 100.00% | 10,472,000 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 0.55% | 0.09% | 696,131 | 191,030 | 37.82% | 36,449,420,000 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.38% | 0.02% | 478,775 | 180,650 | 60.60% | 25,068,659 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 0.37% | 0.01% | 465,673 | 157,969 | 51.34% | 24,382,639 | Jun 30, 2024 |
| FMR LLC | 0.16% | 0.00% | 204,004 | 154,076 | 308.60% | 10,681,651 | Jun 30, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | 0.12% | 0.83% | 152,869 | 152,869 | 100.00% | 8,004,221 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.31% | 0.00% | 397,781 | 152,387 | 62.10% | 20,827,814 | Jun 30, 2024 |
| LSV ASSET MANAGEMENT | 0.48% | 0.07% | 613,800 | 152,000 | 32.91% | 32,139,000 | Jun 30, 2024 |
| RETIREMENT SYSTEMS OF ALABAMA | 0.25% | 0.06% | 315,095 | 149,214 | 89.95% | 16,498,374 | Jun 30, 2024 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 0.56% | 0.16% | 716,573 | 148,212 | 26.08% | 37,519,778 | Jun 30, 2024 |
| INVESCO LTD. | 1.75% | 0.02% | 2,223,938 | 135,528 | 6.49% | 116,445,394 | Jun 30, 2024 |
As of Jun 30 2024, Halozyme Therapeutics's largest institutional buyer is NORGES BANK. The company purchased 1.22M stocks of HALO, valued at $63.68M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| THRIVENT FINANCIAL FOR LUTHERANS | 0.74% | 0.10% | 942,829 | -772,015 | -45.02% | 49,367,000 | Jun 30, 2024 |
| STATE STREET CORP | 4.58% | 0.01% | 5,814,207 | -673,096 | -10.38% | 304,431,879,000 | Jun 30, 2024 |
| BLACKROCK INC. | 13.88% | 0.02% | 17,619,937 | -621,611 | -3.41% | 922,579,902 | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | 0.36% | 0.03% | 452,556 | -353,419 | -43.85% | 23,695,000 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.05% | 0.01% | 58,897 | -336,523 | -85.11% | 3,083,847 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.03% | 0.00% | 40,872 | -322,467 | -88.75% | 2,140,058 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -319,296 | -100.00% | - | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.06% | 0.02% | 80,110 | -318,196 | -79.89% | 4,194,560 | Jun 30, 2024 |
| ELEQUIN SECURITIES, LLC | - | - | - | -272,596 | -100.00% | - | Jun 30, 2024 |
| CUTTER CAPITAL MANAGEMENT, LP | - | - | - | -255,049 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -237,773 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | 0.16% | 0.03% | 197,583 | -202,485 | -50.61% | 10,345,446 | Jun 30, 2024 |
| TD ASSET MANAGEMENT INC | 1.86% | 0.12% | 2,365,983 | -175,283 | -6.90% | 123,882,870 | Jun 30, 2024 |
| LOMBARD ODIER ASSET MANAGEMENT (SWITZERLAND) SA | - | - | - | -175,000 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 2.42% | 0.01% | 3,071,854 | -168,643 | -5.20% | 160,842,277 | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | 0.81% | 0.05% | 1,026,166 | -168,298 | -14.09% | 53,730,051 | Jun 30, 2024 |
| VANGUARD GROUP INC | 10.15% | 0.01% | 12,881,459 | -167,794 | -1.29% | 674,473,194 | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.10% | 0.01% | 129,146 | -167,694 | -56.49% | 6,762,085 | Jun 30, 2024 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 0.01% | 0.00% | 14,580 | -150,999 | -91.19% | 763,409 | Jun 30, 2024 |
| WINTON GROUP LTD | - | - | - | -148,130 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Halozyme Therapeutics's biggest institutional seller is THRIVENT FINANCIAL FOR LUTHERANS. The company sold -0.77M shares of HALO, valued at $49.37M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NORGES BANK | 0.96% | 0.01% | 1,216,161 | 1,216,161 | 100.00% | 63,678,190 | Jun 30, 2024 |
| BOSTON TRUST WALDEN CORP | 0.35% | 0.17% | 443,295 | 443,295 | 100.00% | 23,210,926 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.18% | 0.07% | 227,122 | 227,122 | 100.00% | 11,892,108 | Jun 30, 2024 |
| LOMBARD ODIER ASSET MANAGEMENT (EUROPE) LTD | 0.16% | 0.50% | 200,000 | 200,000 | 100.00% | 10,472,000 | Jun 30, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | 0.12% | 0.83% | 152,869 | 152,869 | 100.00% | 8,004,221 | Jun 30, 2024 |
| CASTELLAN GROUP | 0.09% | 2.71% | 108,922 | 108,922 | 100.00% | 5,703,156 | Jun 30, 2024 |
| CLARK CAPITAL MANAGEMENT GROUP, INC. | 0.08% | 0.04% | 102,925 | 102,925 | 100.00% | 5,389,153 | Jun 30, 2024 |
| CHASE INVESTMENT COUNSEL CORP | 0.07% | 1.80% | 93,777 | 93,777 | 100.00% | 5,182,000 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.06% | 0.01% | 76,580 | 76,580 | 100.00% | 4,006,130 | Jun 30, 2024 |
| READYSTATE ASSET MANAGEMENT LP | 0.05% | 0.10% | 57,970 | 57,970 | 100.00% | 3,035,309 | Jun 30, 2024 |
| CALAMOS ADVISORS LLC | 0.03% | 0.01% | 43,968 | 43,968 | 100.00% | 2,302,164 | Jun 30, 2024 |
| REDHAWK WEALTH ADVISORS, INC. | 0.03% | 0.28% | 35,613 | 35,613 | 100.00% | 1,864,697 | Jun 30, 2024 |
| MARIETTA INVESTMENT PARTNERS LLC | 0.02% | 0.32% | 28,242 | 28,242 | 100.00% | 1,478,751 | Jun 30, 2024 |
| ALTSHULER SHAHAM LTD | 0.02% | 0.05% | 27,000 | 27,000 | 100.00% | 1,413,720 | Jun 30, 2024 |
| ALBERTA INVESTMENT MANAGEMENT CORP | 0.02% | 0.01% | 25,800 | 25,800 | 100.00% | 1,350,888 | Jun 30, 2024 |
| INTECH INVESTMENT MANAGEMENT LLC | 0.02% | 0.01% | 22,763 | 22,763 | 100.00% | 1,191,871 | Jun 30, 2024 |
| JAMES INVESTMENT RESEARCH INC | 0.02% | 0.13% | 21,172 | 21,172 | 100.00% | 1,108,566 | Jun 30, 2024 |
| CHIRON INVESTMENT MANAGEMENT, LLC | 0.01% | 0.39% | 19,011 | 19,011 | 100.00% | 995,416 | Jun 30, 2024 |
| ATRIA INVESTMENTS, INC | 0.01% | 0.01% | 14,981 | 14,981 | 100.00% | 784,406 | Jun 30, 2024 |
| LEGATO CAPITAL MANAGEMENT LLC | 0.01% | 0.10% | 14,613 | 14,613 | 100.00% | 765,137 | Jun 30, 2024 |
| ALGERT GLOBAL LLC | 0.01% | 0.02% | 12,791 | 12,791 | 100.00% | 670,000 | Jun 30, 2024 |
| CHOREO, LLC | 0.01% | 0.01% | 12,736 | 12,736 | 100.00% | 662,604 | Jun 30, 2024 |
| ATRIA WEALTH SOLUTIONS, INC. | 0.01% | 0.01% | 11,552 | 11,552 | 100.00% | 604,863 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.01% | 0.01% | 9,900 | 9,900 | 100.00% | 518,364 | Jun 30, 2024 |
| ALHAMBRA INVESTMENT PARTNERS LLC | 0.01% | 0.26% | 9,190 | 9,190 | 100.00% | 481,188 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.01% | 0.01% | 8,884 | 8,884 | 100.00% | 465,166 | Jun 30, 2024 |
| WOLFF WIESE MAGANA LLC | 0.01% | 0.36% | 8,591 | 8,591 | 100.00% | 449,825 | Jun 30, 2024 |
| ARGENT CAPITAL MANAGEMENT LLC | 0.01% | 0.01% | 8,346 | 8,346 | 100.00% | 436,997 | Jun 30, 2024 |
| 0.01% | 0.05% | 7,331 | 7,331 | 100.00% | 382,018 | Jun 30, 2024 | |
| SHEETS SMITH WEALTH MANAGEMENT | 0.01% | 0.04% | 6,848 | 6,848 | 100.00% | 358,561 | Jun 30, 2024 |
| PROCYON ADVISORS, LLC | 0.00% | 0.02% | 6,266 | 6,266 | 100.00% | 328,088 | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | 0.00% | 0.00% | 6,200 | 6,200 | 100.00% | 324,632 | Jun 30, 2024 |
| MITSUBISHI UFJ TRUST & BANKING CORP | 0.00% | 0.00% | 6,050 | 6,050 | 100.00% | 316,778 | Jun 30, 2024 |
| KESTRA ADVISORY SERVICES, LLC | 0.00% | 0.00% | 4,961 | 4,961 | 100.00% | 259,758 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 0.00% | 0.00% | 4,791 | 4,791 | 100.00% | 250,857 | Jun 30, 2024 |
| O'NEIL GLOBAL ADVISORS, INC. | 0.00% | 0.12% | 4,750 | 4,750 | 100.00% | 249,000 | Jun 30, 2024 |
| RAYMOND JAMES TRUST N.A. | 0.00% | 0.01% | 4,689 | 4,689 | 100.00% | 245,515 | Jun 30, 2024 |
| MIRACLE MILE ADVISORS, LLC | 0.00% | 0.01% | 4,345 | 4,345 | 100.00% | 227,504 | Jun 30, 2024 |
| FIFTH THIRD WEALTH ADVISORS LLC | 0.00% | 0.02% | 4,296 | 4,296 | 100.00% | 224,939 | Jun 30, 2024 |
| CAPSTONE INVESTMENT ADVISORS, LLC | 0.00% | 0.00% | 4,230 | 4,230 | 100.00% | 221,483 | Jun 30, 2024 |
| EVERCORE WEALTH MANAGEMENT, LLC | 0.00% | 0.00% | 4,143 | 4,143 | 100.00% | 216,927 | Jun 30, 2024 |
| VINVA INVESTMENT MANAGEMENT LTD | 0.00% | 0.02% | 4,066 | 4,066 | 100.00% | 315,237 | Jun 30, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 0.00% | 0.00% | 4,000 | 4,000 | 100.00% | 209,440 | Jun 30, 2024 |
| PORTSIDE WEALTH GROUP, LLC | 0.00% | 0.04% | 3,931 | 3,931 | 100.00% | 205,827 | Jun 30, 2024 |
| BELPOINTE ASSET MANAGEMENT LLC | 0.00% | 0.01% | 3,877 | 3,877 | 100.00% | 203,000 | Jun 30, 2024 |
| UNITED CAPITAL FINANCIAL ADVISERS, LLC | 0.00% | 0.00% | 3,858 | 3,858 | 100.00% | 202,005 | Jun 30, 2024 |
| ASHTON THOMAS PRIVATE WEALTH, LLC | 0.00% | 0.01% | 3,720 | 3,720 | 100.00% | 194,779 | Jun 30, 2024 |
| MERCER GLOBAL ADVISORS INC /ADV | 0.00% | 0.00% | 3,484 | 3,484 | 100.00% | 208,933 | Jun 30, 2024 |
| PENSERRA CAPITAL MANAGEMENT LLC | 0.00% | 0.00% | 2,625 | 2,625 | 100.00% | 137,000 | Jun 30, 2024 |
| SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 0.00% | 0.00% | 927 | 927 | 100.00% | 48,542 | Jun 30, 2024 |
| JONES FINANCIAL COMPANIES LLLP | 0.00% | - | 381 | 381 | 100.00% | 19,949 | Jun 30, 2024 |
| BLAIR WILLIAM & CO/IL | 0.00% | 0.00% | 312 | 312 | 100.00% | 16,336 | Jun 30, 2024 |
| RICHARDSON FINANCIAL SERVICES INC. | 0.00% | 0.01% | 260 | 260 | 100.00% | 13,614 | Jun 30, 2024 |
| BOKF, NA | 0.00% | 0.00% | 92 | 92 | 100.00% | 4,817 | Jun 30, 2024 |
| TRIAD WEALTH PARTNERS, LLC | 0.00% | 0.00% | 85 | 85 | 100.00% | 4,451 | Jun 30, 2024 |
| STEPHENS CONSULTING, LLC | 0.00% | 0.00% | 68 | 68 | 100.00% | 3,561 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | 0.00% | 0.00% | 68 | 68 | 100.00% | 3,560 | Jun 30, 2024 |
| COHEN & STEERS, INC. | - | - | 48 | 48 | 100.00% | 2,000 | Jun 30, 2024 |
| FINANCIAL NETWORK WEALTH ADVISORS LLC | - | 0.00% | 28 | 28 | 100.00% | 1,466 | Jun 30, 2024 |
| BENJAMIN F. EDWARDS & COMPANY, INC. | - | - | 23 | 23 | 100.00% | 1,000 | Jun 30, 2024 |
| - | - | 22 | 22 | 100.00% | 1,152 | Jun 30, 2024 | |
| CAPITAL ADVISORS, LTD. LLC | - | 0.00% | 12 | 12 | 100.00% | 1,000 | Jun 30, 2024 |
| RONALD BLUE TRUST, INC. | - | - | 11 | 11 | 100.00% | 447 | Jun 30, 2024 |
| HARBOR INVESTMENT ADVISORY, LLC | - | - | 4 | 4 | 100.00% | 209 | Jun 30, 2024 |
| MV CAPITAL MANAGEMENT, INC. | - | - | 1 | 1 | 100.00% | 53 | Jun 30, 2024 |
Halozyme Therapeutics's largest new institutional shareholder by number of shares is NORGES BANK, purchased 1.22M shares, valued at $63.68M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -319,296 | -100.00% | - | Jun 30, 2024 |
| ELEQUIN SECURITIES, LLC | - | - | - | -272,596 | -100.00% | - | Jun 30, 2024 |
| CUTTER CAPITAL MANAGEMENT, LP | - | - | - | -255,049 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -237,773 | -100.00% | - | Jun 30, 2024 |
| LOMBARD ODIER ASSET MANAGEMENT (SWITZERLAND) SA | - | - | - | -175,000 | -100.00% | - | Jun 30, 2024 |
| WINTON GROUP LTD | - | - | - | -148,130 | -100.00% | - | Jun 30, 2024 |
| AXA S.A. | - | - | - | -135,203 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -75,533 | -100.00% | - | Jun 30, 2024 |
| WAFRA INC. | - | - | - | -53,877 | -100.00% | - | Jun 30, 2024 |
| TORNO CAPITAL, LLC | - | - | - | -50,000 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -24,900 | -100.00% | - | Jun 30, 2024 |
| AIGEN INVESTMENT MANAGEMENT, LP | - | - | - | -24,033 | -100.00% | - | Jun 30, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | - | - | - | -19,129 | -100.00% | - | Jun 30, 2024 |
| ARBOR INVESTMENT ADVISORS, LLC | - | - | - | -17,950 | -100.00% | - | Jun 30, 2024 |
| CAPITAL FUND MANAGEMENT S.A. | - | - | - | -12,400 | -100.00% | - | Jun 30, 2024 |
| OAK HILL WEALTH ADVISORS, LLC | - | - | - | -11,300 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -11,217 | -100.00% | - | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | - | - | - | -11,042 | -100.00% | - | Jun 30, 2024 |
| UNITED SERVICES AUTOMOBILE ASSOCIATION | - | - | - | -10,057 | -100.00% | - | Jun 30, 2024 |
| COASTAL BRIDGE ADVISORS, LLC | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
| INFRASTRUCTURE CAPITAL ADVISORS, LLC | - | - | - | -8,147 | -100.00% | - | Jun 30, 2024 |
| POINT72 (DIFC) LTD | - | - | - | -8,045 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -6,821 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -6,590 | -100.00% | - | Jun 30, 2024 |
| TEZA CAPITAL MANAGEMENT LLC | - | - | - | -5,996 | -100.00% | - | Jun 30, 2024 |
| OLD NATIONAL BANCORP /IN/ | - | - | - | -5,207 | -100.00% | - | Jun 30, 2024 |
| FIDELIS CAPITAL PARTNERS, LLC | - | - | - | -1,284 | -100.00% | - | Jun 30, 2024 |
| SYSTM WEALTH SOLUTIONS LLC | - | - | - | -71 | -100.00% | - | Jun 30, 2024 |
| VITALSTONE FINANCIAL, LLC | - | - | - | -67 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -26 | -100.00% | - | Jun 30, 2024 |
Halozyme Therapeutics's largest sold out institutional shareholder by shares sold is CUBIST SYSTEMATIC STRATEGIES, LLC, sold -0.32M shares, valued at -, as of undefined.
Halozyme Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| FORUM FUNDS | 3.90% | 9,000,000 | - | - | Jan 31, 2024 |
| PROSPECTOR FUNDS, INC. | 2.62% | 772,000 | 772,000 | - | Mar 31, 2024 |
| SPARROW FUNDS | 2.34% | 8,340 | - | - | Feb 29, 2024 |
| BANCROFT FUND LTD | 2.31% | 3,200,000 | 1,000,000 | 45.45% | Dec 29, 2023 |
| ELLSWORTH GROWTH & INCOME FUND LTD | 2.14% | 3,000,000 | 700,000 | 30.43% | Dec 29, 2023 |
| GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC | 1.89% | 1,500,000 | 200,000 | 15.38% | Dec 29, 2023 |
| GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC | 1.64% | 1,300,000 | - | - | Dec 29, 2023 |
| ELLSWORTH GROWTH & INCOME FUND LTD | 1.64% | 2,300,000 | - | - | Dec 29, 2023 |
| AGF Investments Trust | 1.62% | -30,627 | - | - | Mar 31, 2024 |
| BANCROFT FUND LTD | 1.59% | 2,200,000 | - | - | Dec 29, 2023 |
| Virtus Diversified Income & Convertible Fund | 1.27% | 2,590,000 | - | - | Jan 31, 2024 |
| Fiera Capital Series Trust | 1.25% | 24,956 | - | - | Jun 30, 2023 |
| Virtus Dividend, Interest & Premium Strategy Fund | 1.20% | 2,845,000 | - | - | Jan 31, 2024 |
| Virtus Dividend, Interest & Premium Strategy Fund | 1.20% | 2,845,000 | - | - | Jan 31, 2024 |
| Virtus Equity & Convertible Income Fund | 1.18% | 2,330,000 | - | - | Jan 31, 2024 |
| Virtus Equity & Convertible Income Fund | 1.18% | 2,330,000 | - | - | Jan 31, 2024 |
| ADVENT CONVERTIBLE & INCOME FUND | 1.15% | 3,945,000 | - | - | Jan 31, 2024 |
| Calamos Dynamic Convertible & Income Fund | 1.05% | 8,000,000 | - | - | Jan 31, 2024 |
| Virtus Strategy Trust | 1.00% | 21,070,000 | - | - | Mar 28, 2024 |
| Virtus Diversified Income & Convertible Fund | 0.99% | 2,020,000 | - | - | Jan 31, 2024 |
| Virtus Strategy Trust | 0.91% | 19,150,000 | - | - | Mar 28, 2024 |
| ADVENT CONVERTIBLE & INCOME FUND | 0.89% | 3,036,000 | -909,000 | -23.04% | Jan 31, 2024 |
| CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND | 0.81% | 9,250,000 | - | - | Jan 31, 2024 |
| CALAMOS CONVERTIBLE & HIGH INCOME FUND | 0.80% | 10,000,000 | - | - | Jan 31, 2024 |
| Miller Investment Trust | 0.78% | 7,000,000 | - | - | Jan 31, 2024 |
| TETON WESTWOOD FUNDS | 0.77% | 500,000 | 100,000 | 25.00% | Dec 29, 2023 |
| UNIFIED SERIES TRUST | 0.69% | 11,000,000 | - | - | Mar 31, 2024 |
| TETON WESTWOOD FUNDS | 0.62% | 400,000 | - | - | Dec 29, 2023 |
| CALAMOS ADVISORS TRUST/IL | 0.60% | 44,000 | - | - | Mar 31, 2024 |
| CALAMOS ADVISORS TRUST/IL | 0.60% | 44,000 | - | - | Mar 31, 2024 |
| Thrivent ETF Trust | 0.52% | 24,793 | - | - | Mar 31, 2024 |
| Gabelli Healthcare & WellnessRx Trust | 0.50% | 60,000 | 8,081 | 15.56% | Dec 29, 2023 |
| Virtus Convertible & Income Fund | 0.49% | 2,435,000 | - | - | Jan 31, 2024 |
| Virtus Convertible & Income Fund | 0.49% | 2,435,000 | - | - | Jan 31, 2024 |
| Virtus Convertible & Income Fund II | 0.49% | 1,835,000 | - | - | Jan 31, 2024 |
| Virtus Convertible & Income Fund II | 0.49% | 1,835,000 | - | - | Jan 31, 2024 |
| Virtus Investment Trust | 0.48% | 16,420,000 | - | - | Mar 28, 2024 |
| Virtus Investment Trust | 0.47% | 16,055,000 | - | - | Mar 28, 2024 |
| Virtus Dividend, Interest & Premium Strategy Fund | 0.45% | 1,065,000 | - | - | Jan 31, 2024 |
| Virtus Equity & Convertible Income Fund | 0.45% | 885,000 | - | - | Jan 31, 2024 |
| Federated Hermes Equity Income Fund, Inc. | 0.44% | 65,350 | - | - | Feb 29, 2024 |
| PUTNAM CONVERTIBLE SECURITIES FUND | 0.41% | 1,982,000 | - | - | Jan 31, 2024 |
| PUTNAM CONVERTIBLE SECURITIES FUND | 0.41% | 1,982,000 | - | - | Jan 31, 2024 |
| CALAMOS STRATEGIC TOTAL RETURN FUND | 0.40% | 4,435,000 | - | - | Jan 31, 2024 |
| Virtus Diversified Income & Convertible Fund | 0.38% | 780,000 | - | - | Jan 31, 2024 |
| Virtus Strategy Trust | 0.37% | 7,865,000 | - | - | Mar 28, 2024 |
| CALAMOS INVESTMENT TRUST/IL | 0.34% | 35,075,000 | - | - | Jan 31, 2024 |
| HSBC FUNDS | 0.33% | 10,710 | - | - | Jan 31, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.29% | 944,100 | -65,600 | -6.50% | Mar 31, 2024 |
| Clough Global Equity Fund | 0.29% | 18,100 | - | - | Jan 31, 2024 |
| AB DISCOVERY GROWTH FUND, INC. | 0.29% | 431,392 | -5,185 | -1.19% | Jan 31, 2024 |
| BlackRock Innovation & Growth Trust | 0.29% | 302,304 | -108,126 | -26.34% | Mar 31, 2024 |
| SPDR S&P MIDCAP 400 ETF TRUST | 0.28% | 1,080,028 | 9,120 | 0.85% | Mar 28, 2024 |
| Virtus Convertible & Income Fund II | 0.26% | 970,000 | - | - | Jan 31, 2024 |
| Virtus Convertible & Income Fund | 0.25% | 1,230,000 | - | - | Jan 31, 2024 |
| LORD ABBETT DEVELOPING GROWTH FUND, INC. | 0.23% | 211,900 | - | - | Jan 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.21% | 239,119 | -15,139 | -5.95% | Mar 28, 2024 |
| Ultimus Managers Trust | 0.19% | 2,250,000 | - | - | Jan 31, 2024 |
| BNY MELLON MIDCAP INDEX FUND, INC. | 0.19% | 81,684 | -5,219 | -6.01% | Jan 31, 2024 |
| FIDELITY FINANCIAL TRUST | 0.18% | 3,180,000 | - | - | Feb 29, 2024 |
| FIDELITY FINANCIAL TRUST | 0.18% | 3,180,000 | - | - | Feb 29, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.18% | 92,464 | - | - | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.17% | 429,908 | 286,345 | 199.46% | Jan 31, 2024 |
| CALAMOS GLOBAL TOTAL RETURN FUND | 0.16% | 375,000 | - | - | Jan 31, 2024 |
| MERIDIAN FUND INC | 0.16% | 372,820 | 75,686 | 25.47% | Mar 28, 2024 |
| HARTFORD HLS SERIES FUND II INC | 0.16% | 38,589 | - | - | Dec 31, 2023 |
| MAINSTAY VP FUNDS TRUST | 0.15% | 18,801,000 | - | - | Mar 31, 2024 |
| MAINSTAY VP FUNDS TRUST | 0.15% | 18,801,000 | - | - | Mar 31, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.14% | 26,786 | -6,891 | -20.46% | Mar 28, 2024 |
| AIM GROWTH SERIES (INVESCO GROWTH SERIES) | 0.13% | 4,079,000 | - | - | Mar 31, 2024 |
| Calamos Global Dynamic Income Fund | 0.13% | 1,550,000 | - | - | Jan 31, 2024 |
| VANGUARD EXPLORER FUND | 0.13% | 1,596,524 | 143,486 | 9.87% | Jan 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.11% | 1,122,560 | 1,122,416 | 779455.56% | Mar 31, 2024 |
| OBERWEIS FUNDS | 0.09% | 96,300 | - | - | Mar 31, 2024 |
| NUVEEN INVESTMENT TRUST | 0.09% | 49,004 | 14,020 | 40.08% | Mar 31, 2024 |
| BlackRock Health Sciences Trust | 0.08% | 21,055 | - | - | Mar 31, 2024 |
| Clough Global Opportunities Fund | 0.08% | 32,900 | - | - | Jan 31, 2024 |
| M FUND INC | 0.08% | 37,596 | 10,149 | 36.98% | Mar 31, 2024 |
| MAINSTAY FUNDS | 0.08% | 17,827,000 | - | - | Jan 31, 2024 |
| MAINSTAY FUNDS | 0.08% | 17,827,000 | - | - | Jan 31, 2024 |
| BUFFALO FUNDS | 0.07% | 482,634 | 10,500 | 2.22% | Mar 31, 2024 |
| Federated Hermes Index Trust | 0.07% | 16,237 | -656 | -3.88% | Jan 31, 2024 |
| ALGER FUNDS | 0.07% | 69,352 | - | - | Jan 31, 2024 |
| Total Fund Solution | 0.06% | 24,213 | - | - | Mar 31, 2024 |
| VANGUARD ADMIRAL FUNDS | 0.06% | 269,191 | -2,158 | -0.80% | Feb 29, 2024 |
| BlackRock Health Sciences Trust II | 0.06% | 158,300 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY MUTUAL FUNDS, INC. | 0.06% | 597,262 | 40,370 | 7.25% | Jan 31, 2024 |
| Voya PARTNERS INC | 0.06% | 4,845,000 | - | - | Mar 31, 2024 |
| Voya EQUITY TRUST | 0.06% | 85,325 | 4,781 | 5.94% | Feb 29, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.06% | 48,143 | - | - | Mar 31, 2024 |
| SYNTAX ETF TRUST | 0.05% | 1,735 | -65 | -3.61% | Mar 31, 2024 |
| Nuveen S&P 500 Dynamic Overwrite Fund | 0.05% | 1,621 | -351 | -17.80% | Mar 31, 2024 |
| ROYCE VALUE TRUST, INC. | 0.05% | 43,076 | 13,723 | 46.75% | Mar 31, 2024 |
| Voya VARIABLE PRODUCTS TRUST | 0.05% | 19,003 | -909 | -4.57% | Mar 31, 2024 |
| Gabelli Global Small & Mid Cap Value Trust | 0.05% | 5,000 | - | - | Dec 29, 2023 |
| STATE STREET INSTITUTIONAL FUNDS | 0.05% | 41,643 | -11,943 | -22.29% | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.05% | 21,774 | - | - | Mar 31, 2024 |
| ALLSPRING VARIABLE TRUST | 0.05% | 27,900 | -1,000 | -3.46% | Mar 31, 2024 |
| REYNOLDS FUNDS INC | 0.04% | 500 | - | - | Mar 31, 2024 |
| GABELLI ASSET FUND | 0.04% | 15,000 | - | - | Dec 29, 2023 |
Halozyme Therapeutics's largest mutual fund holder by % of total assets is "FORUM FUNDS", owning 9.00M shares, compromising 3.90% of its total assets.
Halozyme Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 218 | -48.10% |
| 31 Mar, 24 | 420 | -0.24% |
| 31 Dec, 23 | 421 | 5.25% |
| 30 Sep, 23 | 400 | 4.99% |
| 30 Jun, 23 | 381 | -2.81% |
| 31 Mar, 23 | 392 | -10.50% |
| 31 Dec, 22 | 438 | 22.01% |
| 30 Sep, 22 | 359 | -3.23% |
| 30 Jun, 22 | 371 | 15.58% |
| 31 Mar, 22 | 321 | -3.02% |
| 31 Dec, 21 | 331 | 0.91% |
| 30 Sep, 21 | 328 | 1.55% |
| 30 Jun, 21 | 323 | -6.38% |
| 31 Mar, 21 | 345 | -0.86% |
| 31 Dec, 20 | 348 | 22.97% |
| 30 Sep, 20 | 283 | 1.80% |
| 30 Jun, 20 | 278 | 25.23% |
| 31 Mar, 20 | 222 | -7.11% |
| 31 Dec, 19 | 239 | 3.91% |
| 30 Sep, 19 | 230 | 5.02% |
| 30 Jun, 19 | 219 | 3.79% |
| 31 Mar, 19 | 211 | 3.43% |
| 31 Dec, 18 | 204 | - |
| 30 Sep, 18 | 204 | -1.45% |
| 30 Jun, 18 | 207 | -9.21% |
| 31 Mar, 18 | 228 | 4.11% |
| 31 Dec, 17 | 219 | 19.67% |
| 30 Sep, 17 | 183 | -1.08% |
| 30 Jun, 17 | 185 | 2.21% |
| 31 Mar, 17 | 181 | -3.21% |
| 31 Dec, 16 | 187 | 6.86% |
| 30 Sep, 16 | 175 | -1.13% |
| 30 Jun, 16 | 177 | -1.12% |
| 31 Mar, 16 | 179 | - |
| 31 Dec, 15 | 179 | -5.29% |
| 30 Sep, 15 | 189 | 9.88% |
| 30 Jun, 15 | 172 | 18.62% |
| 31 Mar, 15 | 145 | 1.40% |
| 31 Dec, 14 | 143 | 10.00% |
| 30 Sep, 14 | 130 | -7.80% |
| 30 Jun, 14 | 141 | -2.08% |
| 31 Mar, 14 | 144 | 9.92% |
| 31 Dec, 13 | 131 | 11.02% |
| 30 Sep, 13 | 118 | 2.61% |
| 30 Jun, 13 | 115 | 112.96% |
| 31 Mar, 13 | 54 | 5.88% |
| 31 Dec, 12 | 51 | 8.51% |
| 30 Sep, 12 | 47 | -9.62% |
| 30 Jun, 12 | 52 | -8.77% |
| 31 Mar, 12 | 57 | 5.56% |
| 31 Dec, 11 | 54 | 22.73% |
| 30 Sep, 11 | 44 | 10.00% |
| 30 Jun, 11 | 40 | -6.98% |
| 31 Mar, 11 | 43 | 10.26% |
| 31 Dec, 10 | 39 | 18.18% |
| 30 Sep, 10 | 33 | -2.94% |
| 30 Jun, 10 | 34 | 13.33% |
| 31 Mar, 10 | 30 | - |
| 31 Dec, 09 | 30 | 25.00% |
| 30 Sep, 09 | 24 | -14.29% |
| 30 Jun, 09 | 28 | 33.33% |
| 31 Mar, 09 | 21 | -19.23% |
| 31 Dec, 08 | 26 | 8.33% |
| 30 Sep, 08 | 24 | 33.33% |
| 30 Jun, 08 | 18 | - |
| 31 Mar, 08 | 18 | - |
| 31 Dec, 07 | 18 | -10.00% |
| 30 Sep, 07 | 20 | 11.11% |
| 30 Jun, 07 | 18 | 50.00% |
| 31 Mar, 07 | 12 | 50.00% |
| 31 Dec, 06 | 8 | 33.33% |
| 30 Sep, 06 | 6 | -14.29% |
| 30 Jun, 06 | 7 | - |
| 31 Mar, 06 | 7 | 75.00% |
| 31 Dec, 05 | 4 | - |
| 30 Sep, 05 | 4 | 33.33% |
| 30 Jun, 05 | 3 | - |
| 31 Mar, 05 | 3 | 50.00% |
| 31 Dec, 04 | 2 | - |
As of 30 Jun 24, 218 institutions are holding Halozyme Therapeutics's shares, representing a decrease of -48.10% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 31,068,640 | -74.65% |
| 31 Mar, 24 | 122,538,335 | -1.36% |
| 31 Dec, 23 | 124,225,834 | 2.20% |
| 30 Sep, 23 | 121,555,932 | -0.35% |
| 30 Jun, 23 | 121,983,398 | -1.84% |
| 31 Mar, 23 | 124,266,899 | -3.50% |
| 31 Dec, 22 | 128,773,797 | -1.70% |
| 30 Sep, 22 | 130,999,797 | 3.14% |
| 30 Jun, 22 | 127,016,992 | 0.51% |
| 31 Mar, 22 | 126,372,155 | -0.88% |
| 31 Dec, 21 | 127,497,006 | -0.79% |
| 30 Sep, 21 | 128,506,608 | -0.14% |
| 30 Jun, 21 | 128,684,898 | -2.07% |
| 31 Mar, 21 | 131,408,797 | -3.55% |
| 31 Dec, 20 | 136,239,015 | 1.78% |
| 30 Sep, 20 | 133,854,418 | -0.95% |
| 30 Jun, 20 | 135,141,728 | 3.47% |
| 31 Mar, 20 | 130,604,512 | 2.53% |
| 31 Dec, 19 | 127,383,352 | 0.82% |
| 30 Sep, 19 | 126,351,290 | 3.14% |
| 30 Jun, 19 | 122,506,467 | 1.21% |
| 31 Mar, 19 | 121,042,256 | 0.03% |
| 31 Dec, 18 | 121,010,179 | -1.57% |
| 30 Sep, 18 | 122,944,837 | 0.23% |
| 30 Jun, 18 | 122,665,515 | -0.66% |
| 31 Mar, 18 | 123,484,745 | 0.83% |
| 31 Dec, 17 | 122,462,706 | 0.82% |
| 30 Sep, 17 | 121,471,286 | -0.40% |
| 30 Jun, 17 | 121,957,591 | 5.84% |
| 31 Mar, 17 | 115,225,513 | 4.08% |
| 31 Dec, 16 | 110,708,920 | 4.45% |
| 30 Sep, 16 | 105,996,982 | 0.85% |
| 30 Jun, 16 | 105,108,565 | 2.37% |
| 31 Mar, 16 | 102,670,565 | 3.87% |
| 31 Dec, 15 | 98,841,404 | -7.51% |
| 30 Sep, 15 | 106,865,333 | 9.52% |
| 30 Jun, 15 | 97,573,013 | 3.35% |
| 31 Mar, 15 | 94,411,459 | 3.31% |
| 31 Dec, 14 | 91,389,930 | 2.69% |
| 30 Sep, 14 | 88,992,868 | 3.87% |
| 30 Jun, 14 | 85,679,114 | -0.46% |
| 31 Mar, 14 | 86,076,846 | 8.28% |
| 31 Dec, 13 | 79,491,831 | 1.96% |
| 30 Sep, 13 | 77,966,492 | 3.62% |
| 30 Jun, 13 | 75,240,961 | 60.93% |
| 31 Mar, 13 | 46,753,529 | 7.19% |
| 31 Dec, 12 | 43,618,754 | 1.03% |
| 30 Sep, 12 | 43,172,735 | -23.13% |
| 30 Jun, 12 | 56,162,408 | 13.27% |
| 31 Mar, 12 | 49,581,533 | 10.70% |
| 31 Dec, 11 | 44,788,863 | 173.24% |
| 30 Sep, 11 | 16,391,530 | -32.18% |
| 30 Jun, 11 | 24,170,782 | 5.79% |
| 31 Mar, 11 | 22,847,844 | 30.90% |
| 31 Dec, 10 | 17,454,446 | 4.18% |
| 30 Sep, 10 | 16,753,970 | 3.98% |
| 30 Jun, 10 | 16,112,429 | 15.80% |
| 31 Mar, 10 | 13,913,565 | -3.95% |
| 31 Dec, 09 | 14,485,355 | 79.67% |
| 30 Sep, 09 | 8,062,026 | -45.44% |
| 30 Jun, 09 | 14,775,273 | 26.46% |
| 31 Mar, 09 | 11,684,175 | -19.75% |
| 31 Dec, 08 | 14,559,198 | 11.97% |
| 30 Sep, 08 | 13,002,486 | 2.55% |
| 30 Jun, 08 | 12,679,181 | 29.80% |
| 31 Mar, 08 | 9,768,359 | 21.32% |
| 31 Dec, 07 | 8,051,719 | 8.14% |
| 30 Sep, 07 | 7,445,497 | 132.10% |
| 30 Jun, 07 | 3,207,881 | -52.24% |
| 31 Mar, 07 | 6,716,500 | -15.03% |
| 31 Dec, 06 | 7,904,457 | 14.71% |
| 30 Sep, 06 | 6,891,000 | 3.92% |
| 30 Jun, 06 | 6,631,300 | -0.80% |
| 31 Mar, 06 | 6,684,700 | 315.25% |
| 31 Dec, 05 | 1,609,800 | -59.38% |
| 30 Sep, 05 | 3,962,800 | -1.81% |
| 30 Jun, 05 | 4,035,800 | 0.92% |
| 31 Mar, 05 | 3,999,000 | 11.02% |
| 31 Dec, 04 | 3,602,100 | - |
Halozyme Therapeutics (HALO) has 31.07M shares outstanding as of 30 Jun 24, down -74.65% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 24.47% | 0.26% |
| 31 Mar, 24 | 96.53% | 1.09% |
| 31 Dec, 23 | 94.16% | 1.11% |
| 30 Sep, 23 | 92.11% | 1.07% |
| 30 Jun, 23 | 92.60% | 1.09% |
| 31 Mar, 23 | 92.03% | 1.02% |
| 31 Dec, 22 | 95.19% | 1.03% |
| 30 Sep, 22 | 95.95% | 1.13% |
| 30 Jun, 22 | 92.08% | 1.09% |
| 31 Mar, 22 | 91.80% | 1.12% |
| 31 Dec, 21 | 90.65% | 1.11% |
| 30 Sep, 21 | 90.48% | 1.11% |
| 30 Jun, 21 | 90.31% | 1.00% |
| 31 Mar, 21 | 95.26% | 0.94% |
| 31 Dec, 20 | 100.84% | 1.05% |
| 30 Sep, 20 | 98.01% | 0.99% |
| 30 Jun, 20 | 99.42% | 1.10% |
| 31 Mar, 20 | 95.20% | 1.22% |
| 31 Dec, 19 | 88.26% | 1.18% |
| 30 Sep, 19 | 86.46% | 1.22% |
| 30 Jun, 19 | 84.25% | 1.20% |
| 31 Mar, 19 | 83.63% | 1.10% |
| 31 Dec, 18 | 87.29% | 1.20% |
| 30 Sep, 18 | 85.41% | 1.17% |
| 30 Jun, 18 | 85.44% | 1.14% |
| 31 Mar, 18 | 86.56% | 1.16% |
| 31 Dec, 17 | 86.41% | 1.17% |
| 30 Sep, 17 | 86.03% | 1.04% |
| 30 Jun, 17 | 91.00% | 1.13% |
| 31 Mar, 17 | 89.59% | 1.13% |
| 31 Dec, 16 | 88.93% | 1.25% |
| 30 Sep, 16 | 84.22% | 1.25% |
| 30 Jun, 16 | 82.14% | 1.27% |
| 31 Mar, 16 | 80.45% | 1.33% |
| 31 Dec, 15 | 77.71% | 1.10% |
| 30 Sep, 15 | 84.20% | 1.41% |
| 30 Jun, 15 | 77.35% | 1.36% |
| 31 Mar, 15 | 75.35% | 1.39% |
| 31 Dec, 14 | 73.54% | 1.43% |
| 30 Sep, 14 | 71.74% | 1.50% |
| 30 Jun, 14 | 69.26% | 1.32% |
| 31 Mar, 14 | 72.37% | 1.46% |
| 31 Dec, 13 | 70.47% | 1.47% |
| 30 Sep, 13 | 69.14% | 1.55% |
| 30 Jun, 13 | 66.89% | 3.87% |
| 31 Mar, 13 | 41.59% | 2.76% |
| 31 Dec, 12 | 38.83% | 2.63% |
| 30 Sep, 12 | 38.44% | 1.53% |
| 30 Jun, 12 | 50.12% | 2.36% |
| 31 Mar, 12 | 46.08% | 2.42% |
| 31 Dec, 11 | 43.67% | 17.32% |
| 30 Sep, 11 | 15.88% | 2.87% |
| 30 Jun, 11 | 23.54% | 4.59% |
| 31 Mar, 11 | 22.64% | 7.49% |
| 31 Dec, 10 | 17.38% | 5.43% |
| 30 Sep, 10 | 17.89% | 5.80% |
| 30 Jun, 10 | 17.56% | 7.61% |
| 31 Mar, 10 | 15.19% | 6.07% |
| 31 Dec, 09 | 15.82% | 19.53% |
| 30 Sep, 09 | 9.00% | 2.84% |
| 30 Jun, 09 | 17.80% | 8.86% |
| 31 Mar, 09 | 14.17% | 4.41% |
| 31 Dec, 08 | 17.92% | 6.84% |
| 30 Sep, 08 | 16.19% | 6.36% |
| 30 Jun, 08 | 15.96% | 10.25% |
| 31 Mar, 08 | 12.48% | 10.63% |
| 31 Dec, 07 | 10.83% | 11.44% |
| 30 Sep, 07 | 9.73% | 50.70% |
| 30 Jun, 07 | 4.38% | 4.76% |
| 31 Mar, 07 | 9.60% | 6.02% |
| 31 Dec, 06 | 12.62% | 10.46% |
| 30 Sep, 06 | 10.98% | 9.55% |
| 30 Jun, 06 | 10.72% | 8.77% |
| 31 Mar, 06 | 11.06% | 155.95% |
| 31 Dec, 05 | 2.66% | 4.24% |
| 30 Sep, 05 | 7.93% | 12.14% |
| 30 Jun, 05 | 8.08% | 12.42% |
| 31 Mar, 05 | 8.07% | 7.80% |
| 31 Dec, 04 | 10.17% | - |
As of 30 Jun 24, Halozyme Therapeutics is held by 24.47% institutional shareholders, representing a 0.26% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 117 | -46.58% |
| 31 Mar, 24 | 219 | 2.82% |
| 31 Dec, 23 | 213 | 18.33% |
| 30 Sep, 23 | 180 | - |
| 30 Jun, 23 | 180 | -4.76% |
| 31 Mar, 23 | 189 | -10.43% |
| 31 Dec, 22 | 211 | 14.05% |
| 30 Sep, 22 | 185 | -12.32% |
| 30 Jun, 22 | 211 | 48.59% |
| 31 Mar, 22 | 142 | -12.88% |
| 31 Dec, 21 | 163 | -9.44% |
| 30 Sep, 21 | 180 | 15.38% |
| 30 Jun, 21 | 156 | -8.24% |
| 31 Mar, 21 | 170 | -15.00% |
| 31 Dec, 20 | 200 | 58.73% |
| 30 Sep, 20 | 126 | -23.17% |
| 30 Jun, 20 | 164 | 74.47% |
| 31 Mar, 20 | 94 | -24.19% |
| 31 Dec, 19 | 124 | 31.91% |
| 30 Sep, 19 | 94 | -14.55% |
| 30 Jun, 19 | 110 | 19.57% |
| 31 Mar, 19 | 92 | -5.15% |
| 31 Dec, 18 | 97 | 14.12% |
| 30 Sep, 18 | 85 | -1.16% |
| 30 Jun, 18 | 86 | -20.37% |
| 31 Mar, 18 | 108 | -7.69% |
| 31 Dec, 17 | 117 | 32.95% |
| 30 Sep, 17 | 88 | -16.98% |
| 30 Jun, 17 | 106 | 51.43% |
| 31 Mar, 17 | 70 | -23.08% |
| 31 Dec, 16 | 91 | 19.74% |
| 30 Sep, 16 | 76 | - |
| 30 Jun, 16 | 76 | -23.23% |
| 31 Mar, 16 | 99 | 22.22% |
| 31 Dec, 15 | 81 | -22.86% |
| 30 Sep, 15 | 105 | 28.05% |
| 30 Jun, 15 | 82 | - |
| 31 Mar, 15 | 82 | 17.14% |
| 31 Dec, 14 | 70 | 12.90% |
| 30 Sep, 14 | 62 | -19.48% |
| 30 Jun, 14 | 77 | -3.75% |
| 31 Mar, 14 | 80 | 21.21% |
| 31 Dec, 13 | 66 | 10.00% |
| 30 Sep, 13 | 60 | -28.57% |
| 30 Jun, 13 | 84 | 140.00% |
| 31 Mar, 13 | 35 | 29.63% |
| 31 Dec, 12 | 27 | -3.57% |
| 30 Sep, 12 | 28 | -15.15% |
| 30 Jun, 12 | 33 | -2.94% |
| 31 Mar, 12 | 34 | -10.53% |
| 31 Dec, 11 | 38 | 35.71% |
| 30 Sep, 11 | 28 | 7.69% |
| 30 Jun, 11 | 26 | -13.33% |
| 31 Mar, 11 | 30 | 36.36% |
| 31 Dec, 10 | 22 | 29.41% |
| 30 Sep, 10 | 17 | -15.00% |
| 30 Jun, 10 | 20 | 25.00% |
| 31 Mar, 10 | 16 | -15.79% |
| 31 Dec, 09 | 19 | 26.67% |
| 30 Sep, 09 | 15 | -21.05% |
| 30 Jun, 09 | 19 | 46.15% |
| 31 Mar, 09 | 13 | -23.53% |
| 31 Dec, 08 | 17 | 13.33% |
| 30 Sep, 08 | 15 | 15.38% |
| 30 Jun, 08 | 13 | 18.18% |
| 31 Mar, 08 | 11 | 37.50% |
| 31 Dec, 07 | 8 | -20.00% |
| 30 Sep, 07 | 10 | -23.08% |
| 30 Jun, 07 | 13 | 62.50% |
| 31 Mar, 07 | 8 | 100.00% |
| 31 Dec, 06 | 4 | 33.33% |
| 30 Sep, 06 | 3 | 200.00% |
| 30 Jun, 06 | 1 | -66.67% |
| 31 Mar, 06 | 3 | - |
| 31 Dec, 05 | 3 | 50.00% |
| 30 Sep, 05 | 2 | 100.00% |
| 30 Jun, 05 | 1 | -50.00% |
| 31 Mar, 05 | 2 | - |
| 31 Dec, 04 | 2 | - |
117 institutional shareholders have increased their position in HALO stock as of 30 Jun 24 compared to 219 in the previous quarter (a -46.58% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 63 | -55.63% |
| 31 Mar, 24 | 142 | -0.70% |
| 31 Dec, 23 | 143 | -2.05% |
| 30 Sep, 23 | 146 | 9.77% |
| 30 Jun, 23 | 133 | -13.64% |
| 31 Mar, 23 | 154 | -12.99% |
| 31 Dec, 22 | 177 | 46.28% |
| 30 Sep, 22 | 121 | 8.04% |
| 30 Jun, 22 | 112 | -10.40% |
| 31 Mar, 22 | 125 | 5.93% |
| 31 Dec, 21 | 118 | 21.65% |
| 30 Sep, 21 | 97 | -9.35% |
| 30 Jun, 21 | 107 | -18.32% |
| 31 Mar, 21 | 131 | 21.30% |
| 31 Dec, 20 | 108 | 8.00% |
| 30 Sep, 20 | 100 | 38.89% |
| 30 Jun, 20 | 72 | -15.29% |
| 31 Mar, 20 | 85 | 28.79% |
| 31 Dec, 19 | 66 | -9.59% |
| 30 Sep, 19 | 73 | 21.67% |
| 30 Jun, 19 | 60 | -4.76% |
| 31 Mar, 19 | 63 | 8.62% |
| 31 Dec, 18 | 58 | -9.38% |
| 30 Sep, 18 | 64 | -13.51% |
| 30 Jun, 18 | 74 | 10.45% |
| 31 Mar, 18 | 67 | 17.54% |
| 31 Dec, 17 | 57 | 11.76% |
| 30 Sep, 17 | 51 | 21.43% |
| 30 Jun, 17 | 42 | -34.38% |
| 31 Mar, 17 | 64 | 30.61% |
| 31 Dec, 16 | 49 | -5.77% |
| 30 Sep, 16 | 52 | -3.70% |
| 30 Jun, 16 | 54 | 35.00% |
| 31 Mar, 16 | 40 | -33.33% |
| 31 Dec, 15 | 60 | 17.65% |
| 30 Sep, 15 | 51 | -8.93% |
| 30 Jun, 15 | 56 | 36.59% |
| 31 Mar, 15 | 41 | 7.89% |
| 31 Dec, 14 | 38 | 8.57% |
| 30 Sep, 14 | 35 | -7.89% |
| 30 Jun, 14 | 38 | 5.56% |
| 31 Mar, 14 | 36 | -2.70% |
| 31 Dec, 13 | 37 | 15.63% |
| 30 Sep, 13 | 32 | 100.00% |
| 30 Jun, 13 | 16 | 14.29% |
| 31 Mar, 13 | 14 | -17.65% |
| 31 Dec, 12 | 17 | 41.67% |
| 30 Sep, 12 | 12 | -14.29% |
| 30 Jun, 12 | 14 | -12.50% |
| 31 Mar, 12 | 16 | 45.45% |
| 31 Dec, 11 | 11 | 22.22% |
| 30 Sep, 11 | 9 | 80.00% |
| 30 Jun, 11 | 5 | -16.67% |
| 31 Mar, 11 | 6 | -40.00% |
| 31 Dec, 10 | 10 | - |
| 30 Sep, 10 | 10 | 11.11% |
| 30 Jun, 10 | 9 | -10.00% |
| 31 Mar, 10 | 10 | 150.00% |
| 31 Dec, 09 | 4 | - |
| 30 Sep, 09 | 4 | -50.00% |
| 30 Jun, 09 | 8 | 100.00% |
| 31 Mar, 09 | 4 | -33.33% |
| 31 Dec, 08 | 6 | 100.00% |
| 30 Sep, 08 | 3 | 200.00% |
| 30 Jun, 08 | 1 | -66.67% |
| 31 Mar, 08 | 3 | -40.00% |
| 31 Dec, 07 | 5 | -28.57% |
| 30 Sep, 07 | 7 | 250.00% |
| 30 Jun, 07 | 2 | -33.33% |
| 31 Mar, 07 | 3 | 50.00% |
| 31 Dec, 06 | 2 | - |
| 30 Sep, 06 | - | -100.00% |
| 30 Jun, 06 | 3 | 50.00% |
| 31 Mar, 06 | 2 | - |
| 31 Dec, 05 | - | -100.00% |
| 30 Sep, 05 | 1 | - |
| 30 Jun, 05 | - | - |
| 31 Mar, 05 | - | - |
| 31 Dec, 04 | - | - |
63 institutional shareholders have reduced their position in HALO stock as of 30 Jun 24 compared to 142 in the previous quarter (a -55.63% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 218 | -48.10% | 31,068,640 | -74.65% | 24.47% | 0.26% | 117 | -46.58% | 63 | -55.63% |
| 31 Mar, 24 | 420 | -0.24% | 122,538,335 | -1.36% | 96.53% | 1.09% | 219 | 2.82% | 142 | -0.70% |
| 31 Dec, 23 | 421 | 5.25% | 124,225,834 | 2.20% | 94.16% | 1.11% | 213 | 18.33% | 143 | -2.05% |
| 30 Sep, 23 | 400 | 4.99% | 121,555,932 | -0.35% | 92.11% | 1.07% | 180 | - | 146 | 9.77% |
| 30 Jun, 23 | 381 | -2.81% | 121,983,398 | -1.84% | 92.60% | 1.09% | 180 | -4.76% | 133 | -13.64% |
| 31 Mar, 23 | 392 | -10.50% | 124,266,899 | -3.50% | 92.03% | 1.02% | 189 | -10.43% | 154 | -12.99% |
| 31 Dec, 22 | 438 | 22.01% | 128,773,797 | -1.70% | 95.19% | 1.03% | 211 | 14.05% | 177 | 46.28% |
| 30 Sep, 22 | 359 | -3.23% | 130,999,797 | 3.14% | 95.95% | 1.13% | 185 | -12.32% | 121 | 8.04% |
| 30 Jun, 22 | 371 | 15.58% | 127,016,992 | 0.51% | 92.08% | 1.09% | 211 | 48.59% | 112 | -10.40% |
| 31 Mar, 22 | 321 | -3.02% | 126,372,155 | -0.88% | 91.80% | 1.12% | 142 | -12.88% | 125 | 5.93% |
| 31 Dec, 21 | 331 | 0.91% | 127,497,006 | -0.79% | 90.65% | 1.11% | 163 | -9.44% | 118 | 21.65% |
| 30 Sep, 21 | 328 | 1.55% | 128,506,608 | -0.14% | 90.48% | 1.11% | 180 | 15.38% | 97 | -9.35% |
| 30 Jun, 21 | 323 | -6.38% | 128,684,898 | -2.07% | 90.31% | 1.00% | 156 | -8.24% | 107 | -18.32% |
| 31 Mar, 21 | 345 | -0.86% | 131,408,797 | -3.55% | 95.26% | 0.94% | 170 | -15.00% | 131 | 21.30% |
| 31 Dec, 20 | 348 | 22.97% | 136,239,015 | 1.78% | 100.84% | 1.05% | 200 | 58.73% | 108 | 8.00% |
| 30 Sep, 20 | 283 | 1.80% | 133,854,418 | -0.95% | 98.01% | 0.99% | 126 | -23.17% | 100 | 38.89% |
| 30 Jun, 20 | 278 | 25.23% | 135,141,728 | 3.47% | 99.42% | 1.10% | 164 | 74.47% | 72 | -15.29% |
| 31 Mar, 20 | 222 | -7.11% | 130,604,512 | 2.53% | 95.20% | 1.22% | 94 | -24.19% | 85 | 28.79% |
| 31 Dec, 19 | 239 | 3.91% | 127,383,352 | 0.82% | 88.26% | 1.18% | 124 | 31.91% | 66 | -9.59% |
| 30 Sep, 19 | 230 | 5.02% | 126,351,290 | 3.14% | 86.46% | 1.22% | 94 | -14.55% | 73 | 21.67% |
| 30 Jun, 19 | 219 | 3.79% | 122,506,467 | 1.21% | 84.25% | 1.20% | 110 | 19.57% | 60 | -4.76% |
| 31 Mar, 19 | 211 | 3.43% | 121,042,256 | 0.03% | 83.63% | 1.10% | 92 | -5.15% | 63 | 8.62% |
| 31 Dec, 18 | 204 | - | 121,010,179 | -1.57% | 87.29% | 1.20% | 97 | 14.12% | 58 | -9.38% |
| 30 Sep, 18 | 204 | -1.45% | 122,944,837 | 0.23% | 85.41% | 1.17% | 85 | -1.16% | 64 | -13.51% |
| 30 Jun, 18 | 207 | -9.21% | 122,665,515 | -0.66% | 85.44% | 1.14% | 86 | -20.37% | 74 | 10.45% |
| 31 Mar, 18 | 228 | 4.11% | 123,484,745 | 0.83% | 86.56% | 1.16% | 108 | -7.69% | 67 | 17.54% |
| 31 Dec, 17 | 219 | 19.67% | 122,462,706 | 0.82% | 86.41% | 1.17% | 117 | 32.95% | 57 | 11.76% |
| 30 Sep, 17 | 183 | -1.08% | 121,471,286 | -0.40% | 86.03% | 1.04% | 88 | -16.98% | 51 | 21.43% |
| 30 Jun, 17 | 185 | 2.21% | 121,957,591 | 5.84% | 91.00% | 1.13% | 106 | 51.43% | 42 | -34.38% |
| 31 Mar, 17 | 181 | -3.21% | 115,225,513 | 4.08% | 89.59% | 1.13% | 70 | -23.08% | 64 | 30.61% |
| 31 Dec, 16 | 187 | 6.86% | 110,708,920 | 4.45% | 88.93% | 1.25% | 91 | 19.74% | 49 | -5.77% |
| 30 Sep, 16 | 175 | -1.13% | 105,996,982 | 0.85% | 84.22% | 1.25% | 76 | - | 52 | -3.70% |
| 30 Jun, 16 | 177 | -1.12% | 105,108,565 | 2.37% | 82.14% | 1.27% | 76 | -23.23% | 54 | 35.00% |
| 31 Mar, 16 | 179 | - | 102,670,565 | 3.87% | 80.45% | 1.33% | 99 | 22.22% | 40 | -33.33% |
| 31 Dec, 15 | 179 | -5.29% | 98,841,404 | -7.51% | 77.71% | 1.10% | 81 | -22.86% | 60 | 17.65% |
| 30 Sep, 15 | 189 | 9.88% | 106,865,333 | 9.52% | 84.20% | 1.41% | 105 | 28.05% | 51 | -8.93% |
| 30 Jun, 15 | 172 | 18.62% | 97,573,013 | 3.35% | 77.35% | 1.36% | 82 | - | 56 | 36.59% |
| 31 Mar, 15 | 145 | 1.40% | 94,411,459 | 3.31% | 75.35% | 1.39% | 82 | 17.14% | 41 | 7.89% |
| 31 Dec, 14 | 143 | 10.00% | 91,389,930 | 2.69% | 73.54% | 1.43% | 70 | 12.90% | 38 | 8.57% |
| 30 Sep, 14 | 130 | -7.80% | 88,992,868 | 3.87% | 71.74% | 1.50% | 62 | -19.48% | 35 | -7.89% |
| 30 Jun, 14 | 141 | -2.08% | 85,679,114 | -0.46% | 69.26% | 1.32% | 77 | -3.75% | 38 | 5.56% |
| 31 Mar, 14 | 144 | 9.92% | 86,076,846 | 8.28% | 72.37% | 1.46% | 80 | 21.21% | 36 | -2.70% |
| 31 Dec, 13 | 131 | 11.02% | 79,491,831 | 1.96% | 70.47% | 1.47% | 66 | 10.00% | 37 | 15.63% |
| 30 Sep, 13 | 118 | 2.61% | 77,966,492 | 3.62% | 69.14% | 1.55% | 60 | -28.57% | 32 | 100.00% |
| 30 Jun, 13 | 115 | 112.96% | 75,240,961 | 60.93% | 66.89% | 3.87% | 84 | 140.00% | 16 | 14.29% |
| 31 Mar, 13 | 54 | 5.88% | 46,753,529 | 7.19% | 41.59% | 2.76% | 35 | 29.63% | 14 | -17.65% |
| 31 Dec, 12 | 51 | 8.51% | 43,618,754 | 1.03% | 38.83% | 2.63% | 27 | -3.57% | 17 | 41.67% |
| 30 Sep, 12 | 47 | -9.62% | 43,172,735 | -23.13% | 38.44% | 1.53% | 28 | -15.15% | 12 | -14.29% |
| 30 Jun, 12 | 52 | -8.77% | 56,162,408 | 13.27% | 50.12% | 2.36% | 33 | -2.94% | 14 | -12.50% |
| 31 Mar, 12 | 57 | 5.56% | 49,581,533 | 10.70% | 46.08% | 2.42% | 34 | -10.53% | 16 | 45.45% |
| 31 Dec, 11 | 54 | 22.73% | 44,788,863 | 173.24% | 43.67% | 17.32% | 38 | 35.71% | 11 | 22.22% |
| 30 Sep, 11 | 44 | 10.00% | 16,391,530 | -32.18% | 15.88% | 2.87% | 28 | 7.69% | 9 | 80.00% |
| 30 Jun, 11 | 40 | -6.98% | 24,170,782 | 5.79% | 23.54% | 4.59% | 26 | -13.33% | 5 | -16.67% |
| 31 Mar, 11 | 43 | 10.26% | 22,847,844 | 30.90% | 22.64% | 7.49% | 30 | 36.36% | 6 | -40.00% |
| 31 Dec, 10 | 39 | 18.18% | 17,454,446 | 4.18% | 17.38% | 5.43% | 22 | 29.41% | 10 | - |
| 30 Sep, 10 | 33 | -2.94% | 16,753,970 | 3.98% | 17.89% | 5.80% | 17 | -15.00% | 10 | 11.11% |
| 30 Jun, 10 | 34 | 13.33% | 16,112,429 | 15.80% | 17.56% | 7.61% | 20 | 25.00% | 9 | -10.00% |
| 31 Mar, 10 | 30 | - | 13,913,565 | -3.95% | 15.19% | 6.07% | 16 | -15.79% | 10 | 150.00% |
| 31 Dec, 09 | 30 | 25.00% | 14,485,355 | 79.67% | 15.82% | 19.53% | 19 | 26.67% | 4 | - |
| 30 Sep, 09 | 24 | -14.29% | 8,062,026 | -45.44% | 9.00% | 2.84% | 15 | -21.05% | 4 | -50.00% |
| 30 Jun, 09 | 28 | 33.33% | 14,775,273 | 26.46% | 17.80% | 8.86% | 19 | 46.15% | 8 | 100.00% |
| 31 Mar, 09 | 21 | -19.23% | 11,684,175 | -19.75% | 14.17% | 4.41% | 13 | -23.53% | 4 | -33.33% |
| 31 Dec, 08 | 26 | 8.33% | 14,559,198 | 11.97% | 17.92% | 6.84% | 17 | 13.33% | 6 | 100.00% |
| 30 Sep, 08 | 24 | 33.33% | 13,002,486 | 2.55% | 16.19% | 6.36% | 15 | 15.38% | 3 | 200.00% |
| 30 Jun, 08 | 18 | - | 12,679,181 | 29.80% | 15.96% | 10.25% | 13 | 18.18% | 1 | -66.67% |
| 31 Mar, 08 | 18 | - | 9,768,359 | 21.32% | 12.48% | 10.63% | 11 | 37.50% | 3 | -40.00% |
| 31 Dec, 07 | 18 | -10.00% | 8,051,719 | 8.14% | 10.83% | 11.44% | 8 | -20.00% | 5 | -28.57% |
| 30 Sep, 07 | 20 | 11.11% | 7,445,497 | 132.10% | 9.73% | 50.70% | 10 | -23.08% | 7 | 250.00% |
| 30 Jun, 07 | 18 | 50.00% | 3,207,881 | -52.24% | 4.38% | 4.76% | 13 | 62.50% | 2 | -33.33% |
| 31 Mar, 07 | 12 | 50.00% | 6,716,500 | -15.03% | 9.60% | 6.02% | 8 | 100.00% | 3 | 50.00% |
| 31 Dec, 06 | 8 | 33.33% | 7,904,457 | 14.71% | 12.62% | 10.46% | 4 | 33.33% | 2 | - |
| 30 Sep, 06 | 6 | -14.29% | 6,891,000 | 3.92% | 10.98% | 9.55% | 3 | 200.00% | - | -100.00% |
| 30 Jun, 06 | 7 | - | 6,631,300 | -0.80% | 10.72% | 8.77% | 1 | -66.67% | 3 | 50.00% |
| 31 Mar, 06 | 7 | 75.00% | 6,684,700 | 315.25% | 11.06% | 155.95% | 3 | - | 2 | - |
| 31 Dec, 05 | 4 | - | 1,609,800 | -59.38% | 2.66% | 4.24% | 3 | 50.00% | - | -100.00% |
| 30 Sep, 05 | 4 | 33.33% | 3,962,800 | -1.81% | 7.93% | 12.14% | 2 | 100.00% | 1 | - |
| 30 Jun, 05 | 3 | - | 4,035,800 | 0.92% | 8.08% | 12.42% | 1 | -50.00% | - | - |
| 31 Mar, 05 | 3 | 50.00% | 3,999,000 | 11.02% | 8.07% | 7.80% | 2 | - | - | - |
| 31 Dec, 04 | 2 | - | 3,602,100 | - | 10.17% | - | 2 | - | - | - |
Halozyme Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Halozyme Therapeutics's stock was made by Torley Helen on Aug 15 2024, selling 3,263 shares at $56.22 per share (valued at $183.44K).
Halozyme Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 6 | 20 | 30.00% |
| Q2 2024 | 19 | 18 | 105.56% |
| Q1 2024 | 32 | 45 | 71.11% |
| Q4 2023 | 6 | 13 | 46.15% |
| Q3 2023 | 9 | 29 | 31.03% |
| Q2 2023 | 18 | 4 | 450.00% |
| Q1 2023 | 26 | 53 | 49.06% |
| Q4 2022 | 2 | 23 | 8.70% |
| Q2 2022 | 7 | - | - |
| Q1 2022 | 20 | 27 | 74.07% |
| Q4 2021 | 4 | 11 | 36.36% |
| Q3 2021 | 6 | 18 | 33.33% |
| Q2 2021 | 12 | 16 | 75.00% |
| Q1 2021 | 21 | 37 | 56.76% |
| Q4 2020 | 1 | 15 | 6.67% |
| Q3 2020 | 1 | 9 | 11.11% |
| Q2 2020 | 10 | 3 | 333.33% |
| Q1 2020 | 27 | 32 | 84.38% |
| Q4 2019 | 1 | 2 | 50.00% |
| Q3 2019 | - | 3 | - |
6 total buy trades, and 20 total sell trades (buy/sell ratio of 0.30%) were made by Halozyme Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 13 | - |
| Q2 2024 | - | 10 | - |
| Q1 2024 | - | 6 | - |
| Q4 2023 | - | 6 | - |
| Q3 2023 | - | 14 | - |
| Q2 2023 | - | 2 | - |
| Q1 2023 | - | 19 | - |
| Q4 2022 | - | 15 | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | 7 | - |
| Q3 2021 | - | 11 | - |
| Q2 2021 | - | 9 | - |
| Q1 2021 | - | 12 | - |
| Q4 2020 | - | 13 | - |
| Q3 2020 | - | 5 | - |
| Q2 2020 | - | 1 | - |
| Q1 2020 | 3 | - | - |
| Q4 2019 | - | - | - |
| Q3 2019 | - | 1 | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 13 open market sell trades of Halozyme Therapeutics's stocks.
Halozyme Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| DICE | DICE Therapeutics, Inc. |
| VRDN | Viridian Therapeutics, Inc. |
| APLS | Apellis Pharmaceuticals, Inc. |
| LRMR | Larimar Therapeutics, Inc. |
| BPMC | Blueprint Medicines Corporation |
| EXEL | Exelixis, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| ALEC | Alector, Inc. |
| BGNE | BeiGene, Ltd. |
| CERE | Cerevel Therapeutics Holdings, Inc. |
| BMRN | BioMarin Pharmaceutical Inc. |
| INBX | Inhibrx, Inc. |
| ALNY | Alnylam Pharmaceuticals, Inc. |
| LEGN | Legend Biotech Corporation |
| ASND | Ascendis Pharma A/S |
| AGIO | Agios Pharmaceuticals, Inc. |
| INSM | Insmed Incorporated |
| PTGX | Protagonist Therapeutics, Inc. |
| CYTK | Cytokinetics, Incorporated |
| RARE | Ultragenyx Pharmaceutical Inc. |
HALO Ownership FAQ
Who Owns Halozyme Therapeutics?
Halozyme Therapeutics is owned by institutional shareholders (24.47%), insiders (1.08%), and public (74.44%). The largest institutional shareholder of Halozyme Therapeutics is BLACKROCK INC. (13.88% of total shares) and the top mutual fund owner is FORUM FUNDS (3.90% of total shares).
Who are the major institutional shareholders of Halozyme Therapeutics?
Halozyme Therapeutics's major institutional shareholders are BLACKROCK INC., VANGUARD GROUP INC, STATE STREET CORP, SNYDER CAPITAL MANAGEMENT L P, and ARTISAN PARTNERS LIMITED PARTNERSHIP. The top five shareholders own together 34.72% of the company's share outstanding.
How many Halozyme Therapeutics shareholders are there?
As of Jun 2024, there are 218 institutional shareholders of Halozyme Therapeutics.
What percentage of Halozyme Therapeutics is owned by BLACKROCK INC?
BLACKROCK INC owns 17.62M shares of Halozyme Therapeutics, representing 13.88% of the company's total shares outstanding, valued at $922.58M (as of Jun 2024).
What percentage of Halozyme Therapeutics is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 12.88M shares of Halozyme Therapeutics (HALO), compromising 10.15% of the company, valued at $674.47M.
What percentage of Halozyme Therapeutics is owned by STATE STREET CORP?
STATE STREET CORP is the third largest holder of Halozyme Therapeutics. The company owns 5.81M of the company's shares outstanding (worth $304.43B).